BioregulatorPreclinicalAnimal Studies

Thyreogen

A peptide bioregulator derived from thyroid tissue containing a complex with glutamic acid, aspartic acid, tyrosine, phenylalanine, proline, and serine.

Preclinical research, approved in Russia as supplement

Regulatory Pathway

Preclinical
Phase I
Phase II
Phase III
Phase IV
Approved

Dosing Protocol

Typical Dose

10-20 mg daily

Frequency

Once or twice daily

Duration

10-30 day cycles

Community-reported dosing. Individual results vary. Not a medical recommendation.
Typical community protocol: 10-20 mg daily via Oral capsules or sublingual, Once or twice daily. Dose range: 10-20 mg daily. Duration: 10-30 day cycles.

Timing & Administration

Administer via Oral capsules or sublingual. Frequency: Once or twice daily.

Mechanism of Action

Contains peptide complex A-2 that regulates gene expression in thyroid tissue. Modulates thyroid function through direct interaction with cellular DNA, supporting healthy thyroid hormone production and metabolic regulation.

Research Summary

Evidence level: animal studies. Clinical status: Preclinical research, approved in Russia as supplement.

Side Effects & Safety

Important Warnings

  • Thyroid bioregulator - may affect thyroid hormone levels
  • Use with caution
  • Not FDA approved.
Generally well-tolerated
may affect thyroid hormone levels
limited safety data outside Russia

References

No references available.